Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study

Oral Oncology ◽  
2016 ◽  
Vol 62 ◽  
pp. 54-59 ◽  
Author(s):  
Elvira del Barco Morillo ◽  
Ricard Mesía ◽  
Juan Carlos Adansa Klain ◽  
Silvia Vázquez Fernández ◽  
Joaquina Martínez-Galán ◽  
...  
2018 ◽  
Vol 35 (3) ◽  
Author(s):  
Hannah Fuchs ◽  
Johannes Pammer ◽  
Christoph Minichsdorfer ◽  
Doris Posch ◽  
Gabriela Kornek ◽  
...  

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e16016-e16016
Author(s):  
M. C. Merlano ◽  
J. B. Vermorken ◽  
H. Wilke ◽  
J. Bourhis ◽  
R. Mesia ◽  
...  

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Doris Posch ◽  
Hannah Fuchs ◽  
Gabriela Kornek ◽  
Anja Grah ◽  
Johannes Pammer ◽  
...  

2021 ◽  
Vol 41 (4) ◽  
pp. 2045-2051
Author(s):  
MOTOYUKI SUZUKI ◽  
YUKINORI TAKENAKA ◽  
TOSHIHIRO KISHIKAWA ◽  
YOSHIFUMI YAMAMOTO ◽  
ATSUSHI HANAMOTO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document